VacV Biotherapeutics
PrivateLast Round
Grant
Aug 28, 2024
Total Funding Raised
$3.62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VacV Biotherapeutics is a biotechnology company developing a novel cancer immunotherapy platform based on its proprietary oncolytic virus technology to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VacV Biotherapeutics Comparables
Compare VacV Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omios Biologics | 86% | |
| ReIGNITE Therapeutics | 83% | |
| KaliVir Immunotherapeutics | 81% | |
VacV Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 28, 2024 | ||||
| Seed | Oct 26, 2022 |
VacV Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 91% MoM.
- Jul 6, 2025
Monthly visitors increased 371% MoM, from 51 to 240.
VacV Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VacV Biotherapeutics's valuation, stock price, and market status.